Novel concepts of neuropeptide-based drug therapy: Vasoactive intestinal polypeptide and its receptors

This publication has 150 references indexed in Scilit:

• Genomic Organization and Regulation of a Human 7-Helix Transmembrane Receptor Which Is Expressed in Pulmonary Epithelial Cells and Induced in Hypoxia
  Biochemical and Biophysical Research Communications, 2002
• Human Intestinal VIP Receptor: Cloning and Functional Expression of Two cDNA Encoding Proteins with Different N-Terminal Domains
  Biochemical and Biophysical Research Communications, 1994
• The VIP₂ receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide
  FEBS Letters, 1993
• Vasoactive intestinal peptide: Involvement of calmodulin and catalytic antibodies
  Neurochemistry International, 1993
• Cloning and Functional Expression of a Human Neuroendocrine Vasoactive Intestinal Peptide Receptor
  Biochemical and Biophysical Research Communications, 1993
• Simultaneous solubilization of high‐affinity receptors for VIP and glucagon and of a low‐affinity binding protein for VIP, shown to be identical to calmodulin
  FEBS Letters, 1993
• Structure‐activity studies of vasoactive intestinal peptide (VIP): cyclic disulfide analogs
  International Journal of Peptide and Protein Research, 1993
• Absence of Immunoreactive Vasoactive Intestinal Polypeptide in Tissue from the Lungs of Patients with Asthma
  New England Journal of Medicine, 1989
• Preferential cleavage of amino- and carboxyl-terminal oligopeptides from vasoactive intestinal polypeptide by human recombinant enkephalinase (neutral endopeptidase, EC 3.4.24.11)
  Biochemical and Biophysical Research Communications, 1989
• Selective localization of vasoactive intestinal peptide and substance P in human eosinophils
  Biochemical and Biophysical Research Communications, 1987